Method for preparing liraglutide intermediate polypeptide
AssigneeAmphastar Nanjing Pharmaceuticals Inc.
InventorsShangshu Pan, Chuangen Tang, Cheng Li, Xiaorui Liu, Huaiyan Cui, Song Chen, Haoning Zhang
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmphastar Nanjing Pharmaceuticals Inc.
InventorsShangshu Pan, Chuangen Tang, Cheng Li, Xiaorui Liu, Huaiyan Cui, Song Chen, Haoning Zhang
Estimating the term…
The invention belongs to the technical field of polypeptide preparation methods, and in particular relates to a preparation method of a liraglutide intermediate polypeptide GLP-1 (7-37). In the preparation method, main steps include constructing recombinant liraglutide engineered bacteria via E. coli to induce expression of a liraglutide intermediate fusion protein in the form of inclusion bodies, and performing denaturation, renaturation, enzyme digestion, separation and purification to obtain the liraglutide intermediate polypeptide GLP-1 (7-37). The invention alters expression pattern into the expression of the intracellular insoluble inclusion bodies by changing a signal peptide of the recombinant sequence to increase significantly expression level. The liraglutide intermediate polypeptide prepared by the invention has a purity up to 87% or more and a yield of more than 85%.
A fusion protein, comprising:
Dependencies are inferred from the claim text.